SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
(Rule 13d-102)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO RULES 13d-1(b),(c), AND (d) AND AMENDMENTS THERETO FILED
PURSUANT TO RULE 13d-2(b)
(Amendment No. )1
Select Medical Corporation
------------------------------------------------------------------
(Name of Issuer)
Common Stock, $.01 par value
-----------------------------------------------------------------
(Title of Class of Securities)
816196 10 9
-----------------------------------------------------------------
(CUSIP Number)
April 5, 2001
-----------------------------------------------------------------
Date of Event Which Requires Filing of this Statement
Check the appropriate box to designate the rule pursuant to which this Schedule
is Filed:
[ ] Rule 13d-1(b)
[ ] Rule 13d-1(c)
[X] Rule 13d-1(d)
--------
1 The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which would
alter disclosures provided in a prior cover page. The information required on
the remainder of this cover page shall not be deemed to be "filed" for the
purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise
subject to the liabilities of that section of the Act but shall be subject to
all other provisions of the Act.
CUSIP No. 816196 10 9 Page 2 of 9 Pages
-----------------------------------------------------------------
1) Name of Reporting Person Welsh, Carson,
I.R.S. Identification Anderson & Stowe
No. of Above Person VII, L.P.
(Entities Only)
-----------------------------------------------------------------
2) Check the Appropriate Box (a) [ X ]
if a Member of a Group (b) [ ]
-----------------------------------------------------------------
3) SEC Use Only
-----------------------------------------------------------------
4) Citizenship or Place Delaware
of Organization
-----------------------------------------------------------------
Number of 5) Sole Voting 9,642,384 shares
Shares Beneficially Power of Common Stock
Owned by Each (including shares
Reporting Person issuable upon exercise
With: of warrants)
------------------------------------
6) Shared Voting
Power -0-
------------------------------------
7) Sole Disposi- 9,642,384 shares of
tive Power Common Stock
(including shares
issuable upon exercise
of warrants)
------------------------------------
8) Shared Dis-
positive Power -0-
------------------------------------
9) Aggregate Amount Beneficially 9,642,384 shares of
Owned by Each Reporting Person Common Stock
(including shares
issuable upon exercise
of warrants)
-----------------------------------------------------------------
10) Check if the Aggregate
Amount in Row (9)
Excludes Certain Shares
-----------------------------------------------------------------
11) Percent of Class
Represented by 20.7%
Amount in Row (9)
-----------------------------------------------------------------
12) Type of Reporting
Person PN
CUSIP No. 816196 10 9 Page 3 of 9 Pages
-----------------------------------------------------------------
1) Name of Reporting Person WCAS Capital
I.R.S. Identification Partners III, L.P.
No. of Above Person
(Entities Only)
-----------------------------------------------------------------
2) Check the Appropriate Box (a) [ X ]
if a Member of a Group (b) [ ]
-----------------------------------------------------------------
3) SEC Use Only
-----------------------------------------------------------------
4) Citizenship or Place Delaware
of Organization
-----------------------------------------------------------------
Number of 5) Sole Voting 2,534,058 shares
Shares Beneficially Power of Common Stock
Owned by Each (including shares
Reporting Person issuable upon exercise
With: of warrants)
------------------------------------
6) Shared Voting
Power -0-
------------------------------------
7) Sole Disposi- 2,534,058 shares of
tive Power Common Stock
(including shares
issuable upon exercise
of warrants)
------------------------------------
8) Shared Dis-
positive Power -0-
------------------------------------
9) Aggregate Amount Beneficially 2,534,058 shares of
Owned by Each Reporting Person Common Stock
(including shares
issuable upon exercise
of warrants)
-----------------------------------------------------------------
10) Check if the Aggregate
Amount in Row (9)
Excludes Certain Shares
-----------------------------------------------------------------
11) Percent of Class
Represented by 5.5%
Amount in Row (9)
-----------------------------------------------------------------
12) Type of Reporting
Person PN
CUSIP No. 816196 10 9 Page 4 of 9 Pages
-----------------------------------------------------------------
1) Name of Reporting Person WCAS Healthcare
I.R.S. Identification Partners, L.P.
No. of Above Person
(Entities Only)
-----------------------------------------------------------------
2) Check the Appropriate Box (a) [ X ]
if a Member of a Group (b) [ ]
-----------------------------------------------------------------
3) SEC Use Only
-----------------------------------------------------------------
4) Citizenship or Place Delaware
of Organization
-----------------------------------------------------------------
Number of 5) Sole Voting 427,511 shares
Shares Beneficially Power of Common Stock
Owned by Each
Reporting Person
With:
------------------------------------
6) Shared Voting
Power -0-
------------------------------------
7) Sole Disposi- 427,511 shares of
tive Power Common Stock
------------------------------------
8) Shared Dis-
positive Power -0-
------------------------------------
9) Aggregate Amount Beneficially 427,511 shares of
Owned by Each Reporting Person Common Stock
-----------------------------------------------------------------
10) Check if the Aggregate
Amount in Row (9)
Excludes Certain Shares
-----------------------------------------------------------------
11) Percent of Class
Represented by 0.9%
Amount in Row (9)
-----------------------------------------------------------------
12) Type of Reporting
Person PN
CUSIP No. 816196 10 9 Page 5 of 9 Pages
Schedule 13G
------------
Item 1(a) - Name of Issuer: Select Medical Corporation
Item 1(b) - Address of Issuer's Principal Executive Offices:
4716 Old Gettysburg Road
Mechanicsburg, PA 17055
Item 2(a) - Name of Person Filing:
This statement is being filed by Welsh, Carson,
Anderson & Stowe VII, L.P., a Delaware limited
partnership ("WCAS VII"), WCAS Capital Partners III,
L.P., a Delaware limited partnership ("WCAS CP III"),
and WCAS Healthcare Partners, L.P., a Delaware
limited partnership ("WCAS HP").
Item 2(b) - Address of Principal Business Office:
320 Park Avenue, Suite 2500
New York, New York 10022
Item 2(c) - Place of Organization:
WCAS VII: Delaware
WCAS CP III: Delaware
WCAS HP: Delaware
Item 2(d) - Title of Class of Securities:
Common Stock, $.01 par value
Item 2(e) - CUSIP Number:
816196 10 9
Item 3 - Statements Filed Pursuant to Rules 13d-1(b) or 13d-2(b):
Not applicable.
Item 4 - Ownership.
(a) Amount Beneficially Owned:
WCAS VII: 9,642,384 shares of Common Stock (including shares
issuable upon exercise of warrants)
WCAS CP III: 2,534,058 shares of Common Stock (including
shares issuable upon exercise of warrants)
WCAS HP: 427,511 shares of Common Stock
(b) Percent of Class:
CUSIP No. 816196 10 9 Page 6 of 9 Pages
WCAS VII: 20.7%
WCAS CP III: 5.5%
WCAS HP: 0.9%
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote:
WCAS VII: 9,642,384 shares of Common Stock (including shares
issuable upon exercise of warrants)
WCAS CP III: 2,534,058 shares of Common Stock (including
shares issuable upon exercise of warrants)
WCAS HP: 427,511 shares of Common Stock
(ii) shared power to vote or to direct the vote: -0-
(iii) sole power to dispose or to direct the disposition of:
WCAS VII: 9,642,384 shares of Common Stock (including shares
issuable upon exercise of warrants)
WCAS CP III: 2,534,058 shares of Common Stock (including
shares issuable upon exercise of warrants)
WCAS HP: 427,511 shares of Common Stock
(iv) shared power to dispose or to direct the
disposition of: -0-
Item 5 - Ownership of Five Percent or Less of a Class:
Not applicable.
Item 6 - Ownership of More than Five Percent on Behalf of Another
Person:
Not applicable.
Item 7 - Identification and Classification of the Subsidiary Which
Acquired the Security Being Reported on By the Parent Company:
Not applicable.
Item 8 - Identification and Classification of Members of the Group:
See Exhibit 2.
Item 9 - Notice of Dissolution of Group:
Not applicable.
Item 10 - Certification:
Not applicable.
CUSIP No. 816196 10 9 Page 7 of 9 Pages
Signature:
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
WELSH, CARSON, ANDERSON & STOWE VII, L.P.
By: WCAS VII Partners, L.P., General
Partner
By /s/ Jonathan M. Rather
--------------------------------------
General Partner
WCAS CAPITAL PARTNERS III, L.P.
By: WCAS CP III Associates, L.L.C., General
Partner
By /s/ Jonathan M. Rather
--------------------------------------
Managing Member
WCAS HEALTHCARE PARTNERS, L.P.
By: WCAS HP Partners, General Partner
By /s/ Jonathan M. Rather
-------------------------------------
Attorney-in-Fact
Date: January 15, 2002
CUSIP No. 816196 10 9 Page 8 of 9 Pages
EXHIBIT 1
AGREEMENT OF
WELSH, CARSON, ANDERSON & STOWE VII, L.P.,
WCAS CAPITAL PARTNERS III, L.P.
AND
WCAS HEALTHCARE PARTNERS, L.P.
PURSUANT TO RULE 13d-1(k)
-------------------------
The undersigned hereby agree that the Information Statement on
Schedule 13G to which this Agreement is annexed as Exhibit 1 is filed on behalf
of each of them in accordance with the provisions of Rule 13d-1(k) under the
Securities Exchange Act of 1934, as amended.
WELSH, CARSON, ANDERSON & STOWE VII, L.P.
By: WCAS VII Partners, L.P., General
Partner
By /s/ Jonathan M. Rather
--------------------------------------
General Partner
WCAS CAPITAL PARTNERS III, L.P.
By: WCAS CP III Associates, L.L.C., General
Partner
By /s/ Jonathan M. Rather
--------------------------------------
Managing Member
WCAS HEALTHCARE PARTNERS, L.P.
By: WCAS HP Partners, General Partner
By /s/ Jonathan M. Rather
-------------------------------------
Attorney-in-Fact
Date: January 15, 2002
CUSIP No. 816196 10 9 Page 9 of 9 Pages
EXHIBIT 2
Identification and Classification
of Members of the Group
---------------------------------
Welsh, Carson, Anderson & Stowe VII, L.P., WCAS Capital Partners III,
L.P. and WCAS Healthcare Partners, L.P. are filing this statement on Schedule
13G as a group. Welsh, Carson, Anderson & Stowe VII, L.P. is a Delaware limited
partnership. Its sole general partner is WCAS VII Partners, L.P., a Delaware
limited partnership.
WCAS Capital Partners III, L.P. is a Delaware limited partnership. Its
sole general partner is WCAS CP III Associates, L.L.C., a Delaware limited
liability company.
WCAS Healthcare Partners, L.P. is a Delaware limited partnership. Its
sole general partner is WCAS HP Partners, a Delaware general partnership.